Morning Consult has published an op-ed by Aimed Alliance’s Executive Director, Stacey L. Worthy. Ms. Worthy argues a significant portion of drug companies’ savings is not being passed onto the public. With little to no prior scrutiny given to pharmacy benefit managers, Ms. Worthy concludes that action must be taken ensure they properly manage prescription drug plans with increased transparency and pass appropriate cost-savings on to consumers. Read the op-ed here.
Last Updated on May 12, 2020 by Aimed Alliance
